Skip to content

Clinical trials

Completed Insulin Resistance trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Status: Completed Country / region: South Korea Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20052
20072
20081
20096
20103
20118
20121
20141
20151
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gachon University Gil Medical Center13
Eli Lilly and Company3
Seoul National University Bundang Hospital3
Seoul National University Hospital3
Sanofi2
Chonbuk National University Hospital1
GlaxoSmithKline1
Korea University1
Samsung Medical Center1
The Korean Society of Ginseng1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance30
Diabetes Mellitus9
Diabetes Mellitus, Type 28
Hypercholesterolemia8
Hypertriglyceridemia4
Hyperglycemia2
Hypertension2
Metabolic Diseases2
Prediabetic State2
Atherosclerosis1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.